Alspaugh Jonathan 4
4 · Aeglea BioTherapeutics, Inc. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
Alspaugh Jonathan
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-23+640,000→ 640,000 totalExercise: $0.44Exp: 2033-02-22→ Common Stock (640,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments beginning on March 23, 2023, until such time as the option is 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.